Jiangsu SEL Biochem

Jiangsu SEL Biochem is a specialized biotechnology company focused on the research, development, and large-scale manufacturing of high-quality peptide active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates advanced manufacturing facilities that comply with international GMP standards, providing contract manufacturing and development services to global pharmaceutical partners. Their product portfolio primarily targets metabolic diseases, including GLP-1 receptor agonists for diabetes and weight management. By leveraging expertise in solid-phase and liquid-phase peptide synthesis, Jiangsu SEL Biochem has established itself as a key supplier in the global peptide drug market.